These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3918399)

  • 1. Reversal of insulin resistance in adipose tissue of non-insulin-dependent diabetics by treatment with diet and sulphonylurea.
    Bolinder J; Ostman J; Arner P
    Acta Endocrinol (Copenh); 1985 Jan; 108(1):85-90. PubMed ID: 3918399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of sulphonylurea therapy on insulin sensitivity in non insulin dependent diabetics.
    Khandekar S; Sethi BK; Dash RJ
    J Assoc Physicians India; 1990 Jul; 38(7):469-71. PubMed ID: 2127273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin receptor binding and metabolic effects of insulin in human subcutaneous adipose tissue in untreated non-insulin dependent diabetes mellitus.
    Arner P; Engfeldt P; Skarfors E; Lithell H; Bolinder J
    Ups J Med Sci; 1987; 92(1):47-58. PubMed ID: 3296383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antilipolytic effect of insulin in non-insulin-dependent diabetes mellitus after conventional treatment with diet and sulfonylurea.
    Bolinder J; Arner P
    Acta Med Scand; 1988; 224(5):451-9. PubMed ID: 3144155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of action of the second-generation sulfonylurea glipizide.
    Lebovitz HE; Feinglos MN
    Am J Med; 1983 Nov; 75(5B):46-54. PubMed ID: 6369967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual actions of sulfonylureas and glyburide. Receptor and post-receptor effects.
    Gavin JR
    Am J Med; 1985 Sep; 79(3B):34-42. PubMed ID: 3931460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of sulfonylureas on adipocyte and skeletal muscle insulin action in patients with non-insulin-dependent diabetes mellitus.
    Pedersen O; Hother-Nielsen O; Bak J; Hjollund E; Beck-Nielsen H
    Am J Med; 1991 Jun; 90(6A):22S-28S. PubMed ID: 1908182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postreceptor defects causing insulin resistance in normoinsulinemic non-insulin-dependent diabetes mellitus.
    Bolinder J; Ostman J; Arner P
    Diabetes; 1982 Oct; 31(10):911-6. PubMed ID: 6759224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adipocyte insulin binding and action in moderately obese NIDDM patients after dietary control of plasma glucose: reversal of postbinding abnormalities.
    Hjøllund E; Pedersen O; Sørensen NS
    Diabetes Care; 1987; 10(3):306-12. PubMed ID: 3595396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glibenclamide improves the response to insulin treatment in non-insulin-dependent diabetics with second failure to sulfonylurea therapy.
    Lins PE; Lundblad S; Persson-Trotzig E; Adamson U
    Acta Med Scand; 1988; 223(2):171-9. PubMed ID: 3126626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous subcutaneous insulin infusion fails to correct impaired basal glucose metabolism and impaired insulin sensitivity of adipocytes from patients with type 1 (insulin-dependent) diabetes.
    Pedersen O; Hjøllund E; Beck-Nielsen H; Richelsen B; Sørensen NS
    Diabetes Res; 1986 Jan; 3(1):17-23. PubMed ID: 3514067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal evaluation of the effects of sulfonylurea therapy in subjects with type II diabetes mellitus.
    Kolterman OG
    Am J Med; 1985 Sep; 79(3B):23-33. PubMed ID: 3931459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The acute and chronic effects of sulfonylurea therapy in type II diabetic subjects.
    Kolterman OG; Gray RS; Shapiro G; Scarlett JA; Griffin J; Olefsky JM
    Diabetes; 1984 Apr; 33(4):346-54. PubMed ID: 6423429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulphonylurea therapy doubles B-cell response to glucose in type 2 diabetic patients.
    Hosker JP; Burnett MA; Davies EG; Harris EA; Turner RC
    Diabetologia; 1985 Nov; 28(11):809-14. PubMed ID: 3936738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-receptor kinase activity of adipose tissue from morbidly obese humans with and without NIDDM.
    Sinha MK; Pories WJ; Flickinger EG; Meelheim D; Caro JF
    Diabetes; 1987 May; 36(5):620-5. PubMed ID: 3032715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Long-term effects of glipizide at the pancreatic and extra-pancreatic level in non-insulin dependent diabetics].
    Sánchez MS; Ordóñez AJ; Villalba MT; de la Viña S; Nash RE; Serrano M
    Rev Med Chil; 1984 Feb; 112(2):107-14. PubMed ID: 6377432
    [No Abstract]   [Full Text] [Related]  

  • 17. Diurnal pattern of plasma insulin and blood glucose during glibenclamide and glipizide therapy in elderly diabetics.
    Groop L; Harno K
    Acta Endocrinol Suppl (Copenh); 1980; 239():44-52. PubMed ID: 6776763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term safety and efficacy of glipizide.
    Feinglos MN; Lebovitz HE
    Am J Med; 1983 Nov; 75(5B):60-6. PubMed ID: 6369969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased insulin binding to adipocytes and monocytes and increased insulin sensitivity of glucose transport and metabolism in adipocytes from non-insulin-dependent diabetics after a low-fat/high-starch/high-fiber diet.
    Hjøllund E; Pedersen O; Richelsen B; Beck-Nielsen H; Sørensen NS
    Metabolism; 1983 Nov; 32(11):1067-75. PubMed ID: 6312251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Site of insulin resistance in type 1 diabetes: insulin-mediated glucose disposal in vivo in relation to insulin binding and action in adipocytes in vitro.
    Yki-Järvinen H; Taskinen MR; Kiviluoto T; Hilden H; Helve E; Koivisto VA; Nikkilä EA
    J Clin Endocrinol Metab; 1984 Dec; 59(6):1183-92. PubMed ID: 6490795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.